FDA: Viatris’ insulin deemed ‘interchangeable’ biosimilar
July 30, 2021Medical Communications
Viatris has become the first company to secure FDA approval for a biosimilar product that is considered completely interchangeable with …
COVID travel update: Double jabbed from US and EU could avoid UK quarantine
July 30, 2021Medical Communications
UK ministers are close to deciding that double vaccinated people from the US and many EU countries will not have …
Positive data reported on Alnylam’s investigational RNAi therapeutic for ultra-rare disease
July 30, 2021Medical Communications
Alnylam Pharmaceuticals has announced that its investigational RNAi therapeutic, lumasiran, has performed well in a Phase III study for the …
FDA grants Huntingdon disease treatment orphan-drug designation
July 30, 2021Medical Communications
The FDA has granted VICO’s investigational therapy for Huntingdon disease, VO659, orphan-drug designation. This news comes just one month after …
Urine test developed that can detect brain tumours for first time
July 29, 2021Scientists from Cancer Research UK have developed a simple urine test that can detect a common type of brain tumours …
Study shows significant improvement of survival in infants with SMA
July 29, 2021sma
Results from the Evrysdi part 2 global FIREFISH study show significant improvement in survival and motor milestones in babies with …
$500,000 grant awarded to NRG Therapeutics for Parkinson’s research
July 29, 2021The Michael J Fox Foundation for Parkinson’s Research (MJFF) has awarded a $500,000 grant to NRG Therapeutics to support its …
Dupilumab meets primary endpoint in skin disease Phase III trial
July 29, 2021Dupilumab has met its primary endpoint in a Phase III trial for patients with moderate-to-severe chronic spontaneous urticaria (CSU), an …
NHS England appoints first ever female Chief Executive
July 29, 2021NHS England has announced the appointment of Amanda Prichard, the first woman to hold the position. She will replace Sir …
Complix and Jiangsu Nhwa to collaborate on treatment of CNS Diseases
July 28, 2021Research and Development
Complix has signed a global collaboration and license agreement with Jiangsu Nhwa Pharmaceutical Co, to develop Cell Penetrating Alphabodies (CPABs), …
US to ship nearly 10 million vaccine doses to Nigeria and South Africa
July 28, 2021Research and Development
On Wednesday the US government will ship 4 million vaccine does to Nigeria and 5.66 million doses to South Africa. …
CanSino’s inhaled COVID vaccine performs well in early trials
July 28, 2021Manufacturing and Production, Research and Development
Early-stage data, published in The Lancet on Monday, has shown CanSino Biologic’s inhaled COVID-19 vaccine was able to stimulate neutralising …
Biogen withdrew Aduhelm paper when asked for edits from JAMA
July 28, 2021Research and Development
The makers of the controversial drug Aduhelm, Biogen, withdrew its paper that analysed the drug’s results that was submitted to …
AstraZeneca & Regeneron to develop small molecule obesity treatment
July 28, 2021Manufacturing and Production, Research and Development
AstraZeneca and Regeneron have announced a collaboration to research, develop and commercialise small molecule compounds directed against the GPR75 target …
Tokyo daily COVID cases hit record high
July 27, 2021Manufacturing and Production, Medical Communications
On Tuesday Tokyo reported 2,848 daily coronavirus infections, the city’s highest rate since the pandemic began. The new infection record …
Byondis and Glycotope to collaborate on antibodies against novel GlycoTargets
July 27, 2021Manufacturing and Production
Byondis and Glycotope have entered into a platform access agreement to discover and develop antibodies that target specific tumour-associated protein/carbohydrate …
BioNTech set to develop first mRNA malaria vaccine
July 27, 2021Manufacturing and Production, Research and Development
Buliding on the success of its COVID-19 vaccine, BioNTech has announced the development of the first mRNA vaccine against malaria, …
Antibodies from Sinovac’s COVID-19 vaccine fade after 6 months, study finds
July 27, 2021Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
A Chinese laboratory study has found that antibodies from Sinovac Biotech’s COVID-19 vaccine drop below a key threshold around six …
Purdue Pharma votes for bankruptcy plan to pay for its role in US opioid crisis
July 27, 2021Manufacturing and Production
Oxycontin makers Purdue Pharma have voted in favour of its bankruptcy reorganisation plan that will provide billions of dollars to …
US purchases further 200M Pfizer vaccines for children and possible boosters
July 26, 2021Sales and Marketing
The Biden administration has purchased an additional 200 million Pfizer-BioNTech COVID-19 vaccines for children, as well as for potential booster …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
